Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.
about
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.
P2860
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Patient-reported outcomes of a ...... ly advanced pancreatic cancer.
@en
Patient-reported outcomes of a ...... ly advanced pancreatic cancer.
@nl
type
label
Patient-reported outcomes of a ...... ly advanced pancreatic cancer.
@en
Patient-reported outcomes of a ...... ly advanced pancreatic cancer.
@nl
prefLabel
Patient-reported outcomes of a ...... ly advanced pancreatic cancer.
@en
Patient-reported outcomes of a ...... ly advanced pancreatic cancer.
@nl
P2093
P2860
P50
P1476
Patient-reported outcomes of a ...... ly advanced pancreatic cancer.
@en
P2093
Amy Hacker-Prietz
Avani D Rao
Christopher L Wolfgang
Daniel A Laheru
Daniel T Chang
Elizabeth A Sugar
George A Fisher
Jonathan S Pai
Joseph M Herman
Karyn A Goodman
P2860
P304
P356
10.1016/J.PRRO.2016.05.005
P577
2016-05-25T00:00:00Z